LONDON (Thomson Financial) - Haemonetics Corp. said Thursday fourth-quarter
net income fell to $13.8 million, or 52 cents a share from $19.8 million, or 72
cents a share in the same quarter a year ago.
Excluding one-time charges, the health care company said it would have
earned $23 million, or 58 cents a share.
Revenue for the three-month period ended March rose 19% to $139 million.
The mean estimate of analysts polled by Thomson Reuters was for earnings of
59 cents a share on revenue of $128.2 million.
For the year ended March 2008, the company is forecasting adjusted earnings
of $2.31 to $2.41 a share on revenue growth of 8% to 11%.
It said its guidance excludes about $7 million to $8 million, or 17 cents to
20 cents a share, in costs related to restructuring parts of its business
including manufacturing and research and development operations.
The Thomson Reuters mean estimate is for fiscal 2009 earnings of $2.47 a
share on revenue of $559 million.
The company said its board of directors has also authorized a $60 million
share repurchase program for fiscal 2009.
mark.cotton@thomsonreuters.com
mc1/pc
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|